Evidence map›Paper›PMID 32721799›Full record

ArticleMedical hypotheses2020

SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.

Rubens Cecchini, Alessandra Lourenço Cecchini

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Medical hypotheses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05520918 (Clinical Demonstration of a Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients), which is not on this map. Cited by 242 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
242citing papers in PubMed, 1 pooled it
37.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05520918 nacompletednot on this mapstarted 2021, after this paper: background citation

Clinical Demonstration of a Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients

TypeinterventionalSponsorGazi UniversityRan2021 to 2021Enrolled63ConditionsCOVID-19 PneumoniaArmsthe LIT test
3 · Its place in the literature

Who cites it

242 citing papers in PubMed, 1 synthesis or guideline pooled it, 400 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. COVID-19 Infection, Drugs, and Liver Injury.Journal of clinical medicine · 2025
    Review
  17. Review
  18. Article
  19. Review
  20. Review

182 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rubens CecchiniLaboratory of Pathophysiology and Free Radicals, Department of Pathological Sciences, State University of Londrina, UEL, Londrina, PR, Brazil.
Alessandra Lourenço CecchiniLaboratory of Molecular Pathology, Department of Pathological Sciences, State University of Londrina, UEL, Londrina, PR, Brazil. Electronic address: alcecchini@uel.br.
Universidade Estadual de Londrina · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the WHO declared COVID-19 a pandemic, a great effort has been made to understand this serious disease. Thousands of studies are being devoted to understanding its epidemiology, its molecular characteristics, its mechanisms, and the clinical evolution of this viral infection. However, little has been published on its pathogenesis and the host response mechanisms in the progress of the disease. Therefore, we propose a hypothesis based on strong scientific documentation, associating oxidative stress with changes found in patients with COVID-19, such as its participation in the amplification and perpetuation of the cytokine storm, coagulopathy, and cell hypoxia. Finally, we suggest a therapeutic strategy to reduce oxidative stress using antioxidants, NF-κB inhibitors, Nrf2 activators, and iron complexing agents. We believe that this hypothesis can guide new studies and therapeutic strategies on this topic.

Indexed as

Oxidative StressAntioxidantsBetacoronavirusCoronavirus InfectionsCOVID-19CytokinesDisease ProgressionHumansHypoxiaIronNF-E2-Related Factor 2NF-kappa BPandemicsPneumonia, ViralSARS-CoV-2AntioxidantsCytokinesIronNFE2L2 protein, humanNF-E2-Related Factor 2NF-kappa BAntioxidantsCOVID-19HypoxiaNF-κBNrf-2Sepsis

Identifiers

PMID32721799
PMCPMC7357498
OpenAlexW3041774684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.